Needs review

Curated date: 2024/10/26

Curator: MyleeeA

Revision editor(s): MyleeeA

Source: Supplementary Figure 5

Description: Differentially Abundant taxa between the Low Risk (LR)/Medium Risk (MR) and High Risk (HR) groups Without medication use determined using linear discriminant analysis effect size (LEfSe) analysis.

Abundance in Group 1: increased abundance in High Risk (HR) Without Medication use

NCBI Quality ControlLinks
Actinomycetaceae
Porphyromonas
Sphingobacterium
Actinobaculum
Thermoplasmata
Raoultella
E2E2
Pseudoxanthomonas
Desulfovibrio
Desulfovibrionaceae
Desulfovibrionales
Deltaproteobacteria
Burkholderiales
Betaproteobacteria

Revision editor(s): MyleeeA